These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38392056)

  • 1. Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT.
    Maggio A; Rancati T; Gatti M; Cante D; Avuzzi B; Bianconi C; Badenchini F; Farina B; Ferrari P; Giandini T; Girelli G; Landoni V; Magli A; Moretti E; Petrucci E; Salmoiraghi P; Sanguineti G; Villa E; Waskiewicz JM; Guarneri A; Valdagni R; Fiorino C; Cozzarini C
    Curr Oncol; 2024 Feb; 31(2):839-848. PubMed ID: 38392056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial.
    Murthy V; Maitre P; Bhatia J; Kannan S; Krishnatry R; Prakash G; Bakshi G; Pal M; Menon S; Mahantshetty U
    Radiother Oncol; 2020 Apr; 145():71-80. PubMed ID: 31923712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of quality of life 54 months after high-dose intensity-modulated radiotherapy for localized prostate cancer.
    Goineau A; Marchand V; Rigaud J; Bourdin S; Rio E; Campion L; Bonnaud-Antignac A; Mahé MA; Supiot S
    Radiat Oncol; 2013 Mar; 8():53. PubMed ID: 23510499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
    Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
    Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
    Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
    [No Abstract]   [Full Text] [Related]  

  • 6. No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
    Marchand V; Bourdin S; Charbonnel C; Rio E; Munos C; Campion L; Bonnaud-Antignac A; Lisbona A; Mahé MA; Supiot S
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1053-9. PubMed ID: 19880259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
    Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.
    Joseph K; Balushi MA; Ghosh S; Stenson T; Abraham A; Elangovan A; Warkentin H; Paulson K; Tankel K; Usmani N; Severin D; Schiller D; Wong C; Mulder K; Doll C; King K; Nijjar T
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):434-445. PubMed ID: 37148982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients.
    Norkus D; Karklelyte A; Engels B; Versmessen H; Griskevicius R; De Ridder M; Storme G; Aleknavicius E; Janulionis E; Valuckas KP
    Radiat Oncol; 2013 Sep; 8():206. PubMed ID: 24007322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy.
    Pervez N; Small C; MacKenzie M; Yee D; Parliament M; Ghosh S; Mihai A; Amanie J; Murtha A; Field C; Murray D; Fallone G; Pearcey R
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):57-64. PubMed ID: 19395192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer.
    Adkison JB; McHaffie DR; Bentzen SM; Patel RR; Khuntia D; Petereit DG; Hong TS; Tomé W; Ritter MA
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):184-90. PubMed ID: 21163590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
    Fransson P; Nilsson P; Gunnlaugsson A; Beckman L; Tavelin B; Norman D; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Zackrisson B; Kjellén E; Franzén L; Widmark A
    Lancet Oncol; 2021 Feb; 22(2):235-245. PubMed ID: 33444529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helical tomotherapy for prostate cancer radiation therapy: An audit of early toxicity and quality of life.
    Kunheri B; Lakshmi JS; Ravindran GC; Haridas ; Marwaha V
    J Cancer Res Ther; 2021; 17(2):366-371. PubMed ID: 34121678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study.
    Jorgo K; Polgar C; Major T; Stelczer G; Herein A; Pocza T; Gesztesi L; Agoston P
    Pathol Oncol Res; 2020 Apr; 26(2):905-912. PubMed ID: 30888646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial.
    Leite ETT; Ramos CCA; Ribeiro VAB; Salvajoli BP; Nahas WC; Salvajoli JV; Ynoe Moraes F
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1263-1270. PubMed ID: 33346091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: implications for defining postradiotherapy urinary toxicity.
    Ghadjar P; Jackson A; Spratt DE; Oh JH; Munck af Rosenschöld P; Kollmeier M; Yorke E; Hunt M; Deasy JO; Zelefsky MJ
    Eur Urol; 2013 Dec; 64(6):931-8. PubMed ID: 23522772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
    Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
    Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial.
    Niazi T; Nabid A; Malagon T; Bettahar R; Vincent L; Martin AG; Jolicoeur M; Yassa M; Barkati M; Igidbashian L; Bahoric B; Archambault R; Villeneuve H; Tsui JMG; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):52-62. PubMed ID: 37224928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial.
    Viani GA; Viana BS; Martin JE; Rossi BT; Zuliani G; Stefano EJ
    Cancer; 2016 Jul; 122(13):2004-11. PubMed ID: 27028170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of radiotherapy on quality of life for cancer patients: a longitudinal study.
    Yucel B; Akkaş EA; Okur Y; Eren AA; Eren MF; Karapinar H; Babacan NA; Kiliçkap S
    Support Care Cancer; 2014 Sep; 22(9):2479-87. PubMed ID: 24728584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.